Farley Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.07M Sell
51,725
-220,423
-81% -$3.5M 1.51% 6
2017
Q3
$3.9M Hold
272,148
4.36% 4
2017
Q2
$4.71M Hold
272,148
5.35% 4
2017
Q1
$3M Hold
272,148
3.68% 4
2016
Q4
$3.95M Sell
272,148
-26,500
-9% -$486K 5.22% 4
2016
Q3
$7.33M Sell
298,648
-8,810
-3% -$228K 9.7% 3
2016
Q2
$6.19M Hold
307,458
9.65% 3
2016
Q1
$8.09M Buy
307,458
+85,176
+38% +$6.3M 11.46% 3
2015
Q4
$22.6M Buy
222,282
+30,152
+16% +$3.39M 25.68% 2
2015
Q3
$34.3M Buy
192,130
+51,110
+36% +$11.9M 27.18% 2
2015
Q2
$31.3M Hold
141,020
24.16% 2
2015
Q1
$28M Sell
141,020
-121,900
-46% -$21.6M 22.1% 2
2014
Q4
$37.6M Sell
262,920
-78,598
-23% -$10.6M 26.64% 1
2014
Q3
$44.8M Buy
341,518
+8,437
+3% +$1.01M 30.12% 1
2014
Q2
$42M Buy
333,081
+55,269
+20% +$7.05M 27.09% 1
2014
Q1
$36.6M Buy
277,812
+30,691
+12% +$4.2M 22.59% 2
2013
Q4
$29M Hold
247,121
18.09% 3
2013
Q3
$25.8M Buy
247,121
+265
+0.1% +$25.8K 17.78% 3
2013
Q2
$21.2M Buy
+246,856
New +$19.5M 16.14% 4

Other funds holding BHC

Farley Capital's BHC Position: Q4 2017 in Review

Farley Capital reduced its Bausch Health (BHC) stake by 81% in Q4 2017, selling an estimated $3.5M and leaving 51,725 shares worth $1.07M. The position accounts for 1.51% of the portfolio, ranked #6.

Farley Capital first reported a position in BHC in Q2 2013 and has held it in 19 quarters since. The position peaked at $44.8M in Q3 2014. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2017.

  • Farley Capital held 51,725 shares of Bausch Health worth $1.07M as of Q4 2017.
  • Farley Capital sold 220,423 Bausch Health shares in Q4 2017, an estimated $3.5M.
  • Bausch Health made up 1.51% of Farley Capital's portfolio in Q4 2017, its #6 holding.
  • Farley Capital first reported a position in Bausch Health in Q2 2013 and has held it in 19 quarters since.
  • Farley Capital's Bausch Health position peaked at $44.8M in Q3 2014.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2017.

Based on Farley Capital's 13F filing for Q4 2017, filed 13 Feb 2018.